Medications for Opioid Use Disorder (MOUD)
Medications for Opioid Use Disorders (MOUD) involve a combination of a medications that targets the brain, and psychosocial interventions (e.g., counseling, skills development) aimed at improving treatment outcomes. SAMHSA and the ACOG recommend treatment with methadone or buprenorphine for pregnant women with opioid use disorder, in conjunction with behavioral therapy and medical services. More from ACOG.
MACS provides trainings for Maryland maternal health providers to provide medications for opioid use disorder. Buprenorphine is one of three medications approved by the FDA for the treatment of opioid use disorder in pregnant people.
For more information on prescribing bupernorphine for OUD: https://www.marylandmacs.org/mat--mate-acts/expanding-access-to-buprenorphine/
Additional Training Resources
The Maryland Addiction Consultation Service is administered by the University of Maryland School of Medicine and funded by the Maryland Department of Health, Behavioral Health Administration.